SEC Form 4 · accession 0001179110-15-009516
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nesli Basgoz
Director
Period of report
Jun 9, 2015
Accepted (ET)
Jun 10, 2015 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001 | Jun 9, 2015 | M | 2,200 | $82.53 | A | 6,486 | D | |
| Ordinary Shares, par value $0.0001F1 | Jun 9, 2015 | S | 2,200 | $297.89 | D | 4,286 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $82.53 | Jun 9, 2015 | M | 2,200 | D | — | May 18, 2016 | Ordinary Shares | 2,200 | 2,759 | D |
Explanation of responses
- F1Includes 674 restricted stock units of the Issuer and 826 shares of restricted stock of the Issuer.
- F2This option became vested and exercisable in four equal installments commencing on May 18, 2006.